Oxford University’s COVID-19 vaccine has passed another test this week, with trials showing the injection led to the making of antibodies and T-cells that can fight coronavirus. We had the inside running on this. Professor Adrian Hill, who is the director of the Jenner Institute which developed the vaccine spoke at our Fiduciary Investors Global Symposium last month. You can watch the video recording of his description of the vaccine process, and his positive outlook on the results here.
Amanda WhiteJuly 22, 2020
COVID-19 has revealed some fundamental design flaws in our global economy, including the relentless pursuit of economic growth - not only at the expense of the environment but also at the expense of people. The investment industry has a role to play in fixing these design flaws. A systems framework for investing could be the answer.
Marisa HallJuly 16, 2020
Credit opportunities within long-only fixed income, hedge funds and private markets are broad and likely to expand as the economic impact of COVID-19 is reflected in corporate earnings and balance sheets. This type of environment has historically led to investment opportunities for long-term investors across the credit spectrum. Investors seeking to benefit from credit dislocation should ensure that suitable portfolio allocations are in place.
Joe Abrams, Daniel Natale and Scott ZipfelJuly 16, 2020
The only solution to the problem of COVID-19 is a vaccination. Oxford University's Jenner Institute is one of the organization's racing to provide a vaccine, and it's director Adrian Hill believes the Institute could have cracked it by year-end.
Sarah RundellJune 29, 2020
In our second feature looking ahead to FIS 2020, we highlight how the conference will focus on growing calls for a sustainable recovery and purposeful companies. Nobel prize winner Esther Duflo will talk on solutions to inequality, magnified during the pandemic.
Sarah RundellJune 11, 2020